# EDGAR Filing Document

**Accession Number:** 0001141788
**File Stem:** 0001683168-26-004795
**Filing Date:** 2026-6
**Character Count:** 2816
**Document Hash:** fc8eedb6c21cd076c6ffcc549bb17b39
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-26-004795.hdr.sgml**: 20260612

**ACCESSION NUMBER**: 0001683168-26-004795

**CONFORMED SUBMISSION TYPE**: 15-15D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260612

**DATE AS OF CHANGE**: 20260612

**EFFECTIVENESS DATE**: 20260612

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HEALTH DISCOVERY CORP
- **CENTRAL INDEX KEY:** 0001141788
- **STANDARD INDUSTRIAL CLASSIFICATION:** PATENT OWNERS & LESSORS [6794]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 743002154
- **STATE OF INCORPORATION:** GA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 15-15D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-62216
- **FILM NUMBER:** 261085906

**BUSINESS ADDRESS:**
- **STREET 1:** POST OFFICE BOX 616
- **CITY:** DEVAULT
- **STATE:** PA
- **ZIP:** 19432
- **BUSINESS PHONE:** 1-847-721-1200

**MAIL ADDRESS:**
- **STREET 1:** POST OFFICE BOX 616
- **CITY:** DEVAULT
- **STATE:** PA
- **ZIP:** 19432

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DIRECT WIRELESS COMMUNICATIONS INC
- **DATE OF NAME CHANGE:** 20010531

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 15**

**CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION**

**12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE** 

**REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**Commission File Number: <u>333-62216</u>**

**Health Discovery Corporation**

(Exact name of registrant as specified in its charter)

**Post Office Box 616, Devault, PA 19432 1-847-721-1200**

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

**Common Stock, no par value**

(Title of each class of securities covered by this Form)

**n/a**

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

---

| | |
|:---|:---|
| Rule 12g-4(a)(1) | ☐ |
| Rule 12g-4(a)(2) | ☐ |
| Rule 12h-3(b)(1)(i) | ☐ |
| Rule 12h-3(b)(1)(ii) | ☐ |
| Rule 12h-3(b)(1)(ii) | ☐ |
| Rule 15d-6 | ☒ |
| Rule 15d-22(b) | ☐ |

---

Approximate number of holders of record as of the certification or notice date:  **<u>276</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, Health Discovery Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

---

| | | | |
|:---|:---|:---|:---|
| Date: June 11, 2026 | By: | /s/ Alan Hauser | /s/ Alan Hauser |
|  |  | Name: | Alan Hauser |
|  |  | Title: | Chief Executive Officer |

---